Neuropharmacology, Addiction and Autonomy: A Proposal for Public Policy on Adderall and Ritalin as Pharmacological Enhancements

0Citations
Citations of this article
4Readers
Mendeley users who have this article in their library.
Get full text

Abstract

The use of medical drugs such as Adderall (mixed amphetamine salts) and Ritalin (methylphenidate) by healthy adults for enhancement of cognitive function is a social trend that has gained in momentum (see, e.g., DeSantis et al. in J Am Coll Health 57(3):315–324, 2008; Maher in Nature 452(7188):674–675, 2008; Ragan et al. in Neuropharmacology 64:588–595, 2012), and accordingly has generated a lot of attention in academia (for an overview see Racine in Pragmatic neuroethics: improving treatment and understanding of the mind-brain. MIT Press, Cambridge, 2010, Chap. 6).

Cite

CITATION STYLE

APA

Dubljević, V. (2019). Neuropharmacology, Addiction and Autonomy: A Proposal for Public Policy on Adderall and Ritalin as Pharmacological Enhancements. In International Library of Ethics, Law and Technology (Vol. 19, pp. 45–63). Springer Science and Business Media B.V. https://doi.org/10.1007/978-3-030-13643-7_4

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free